# A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization

> **NCT00797108** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 35 (actual)

## Conditions studied

- Pneumonia, Bacterial

## Interventions

- **DRUG:** sulopenem and PF-03709270
- **DRUG:** Sulopenem and PF-03709270
- **DRUG:** Ceftriaxone and amoxicillin/clavulanate

## Key facts

- **NCT ID:** NCT00797108
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2016-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797108, "A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00797108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*